Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-16

Clinical Trial Update: FlexNav EU CE Mark Study [NA]

View source ↗

Summary

Clinical trial update for the FlexNav EU CE Mark study has completed with results posted in 2021, involving symptomatic severe aortic stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FlexNav (null)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Symptomatic Severe Aortic Stenosis | NA | Status: COMPLETED | Results posted: 2021-03-16